Operations differences that matter
Lyophilized presentations may simplify receiving for clinics without -80°C capacity; cryopreserved presentations typically need dry-ice shipping and qualified freezers.
Confirm the insert for each SKU; do not generalize across brands or sizes.
Analytical figures are not outcomes
Particle counts and growth-factor panels, when listed, are analytical. They are not proof of clinical performance.
Compare how each supplier ties figures to lots before comparing magnitudes.
Logistics and multi-site readiness
Compare dry-ice versus ambient or lyophilized shipping, cut-off times, weekend receiving constraints, and how backorders are communicated.
Multi-location groups should test a pilot order before enterprise rollout.
Operational checklist for lyophilized vs cryopreserved exosomes
Before ordering under the topic lyophilized vs cryopreserved exosomes, confirm storage class, receiving owner, and which documents will be required at release.
Close open items in writing. Do not infer missing COA fields from a different lot or SKU.
Frequently asked questions
Is a larger vial stronger?+
Not as a clinical claim. It is a different presentation to verify on the label.
Can we treat similar perinatal tissues as interchangeable?+
No. Confirm tissue type and keep separate files.
What should win a comparison?+
Documentation completeness, logistics fit, and claim discipline—not slogans.
Does this page determine how we may use products discussed under lyophilized vs cryopreserved exosomes?+
No. Intended use remains with the ordering physician and clinic counsel.